Table 3.
Effects of different covariates on overall survival
| Covariates | Relative risk | Confidence interval | P |
|---|---|---|---|
| Univariate analysis | |||
| Initial or delayed CMR | 0.1033 | 0.0212–0.5039 | 0.0052 |
| SULtotal | 1.0509 | 1.0105–1.0930 | 0.0135 |
| Bone metastases | 4.4438 | 1.2266–16.0992 | 0.0239 |
| SUVmax | 1.0868 | 1.0031–1.1774 | 0.0429 |
| Presence of metastases | 3.3590 | 0.9697–11.6355 | 0.0572 |
| Initial CMR | 0.2306 | 0.0496–1.0722 | 0.0627 |
| PMD | 3.2099 | 0.9201–11.1986 | 0.0688 |
| Liver metastases | 2.9000 | 0.8246–10.1987 | 0.0987 |
| Number of lesions | 1.0592 | 0.9829–1.1415 | 0.1337 |
| ED vs LD | 2.4348 | 0.7299–8.1221 | 0.1498 |
| Gender | 0.8259 | 0.2476–2.7546 | 0.7568 |
| PMR | 1.1910 | 0.3138–4.5197 | 0.7983 |
| Age | 0.9958 | 0.9358–1.0597 | 0.8949 |
| SMD | 1.0039 | 0.2170–4.6432 | 0.9961 |
| Multivariate analysis | |||
| Initial or delayed CMR | 0.1030 | 0.0198–0.5356 | 0.0072 |
| SULtotal | 1.0461 | 1.0030–1.0911 | 0.0365 |